Back to Schonfeld Strategic Advisors LLC Schonfeld Strategic Advisors LLC

DYNDYN
10 quarters

Position history for Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC's holdings in DYNE THERAPEUTICS INC

Yes. Schonfeld Strategic Advisors holds 134,752 shares of DYN (Dyne Therapeutics), worth $3M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$3M

Current Shares

134,752

Total Value Change

-$673,955

Total Shares Change

-140,947

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
134,752
-
$3M0.0%$22.21
36
2025-Q4
Exited
0
-100.0%
$00.0%$19.20
0
2025-Q3
Increased
415,927
+24.7%
$5.3M0.0%$12.37
33
2025-Q2
Increased
333,453
+127.9%
$3.2M0.0%$9.57
43
2025-Q1
New
146,294
-
$1.5M0.0%$11.45
35
2024-Q4
Exited
0
-100.0%
$00.0%$23.65
0
2024-Q3
Decreased
36,352
-68.4%
$1.3M0.0%$33.83
0
2024-Q2
Decreased
115,195
-57.3%
$4.1M0.0%$35.29
0
2024-Q1
Decreased
269,757
-2.2%
$7.7M0.1%$28.39
0
2023-Q4
New
275,699
-
$3.7M0.0%$13.30
37

Other major holders of DYN: FMR LLC, BlackRock, Inc., Janus Henderson Group Ltd., Jupiter Topco LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used